The Icahn School of Medicine at Mount Sinai was awarded a $2 million grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to study which ...
The U.S. Food and Drug Administration (FDA) has accepted CeleCor Therapeutics ' new drug application (NDA) for zalunfiban (Disaggpro). The investigational drug was developed to treat ST-elevation ...
The establishment of dedicated CPT codes represents an important step in the broader reimbursement for renal denervation to ...
Children with congenital heart disease outgrow their replacement valves, requiring repeat open-heart surgeries. The Autus can ...
Research has shown that mistreatment at the hands of patients and other visitors is one of the leading drivers of burnout in ...
The U.S. Food and Drug Administration (FDA) expanded the indication for Bristol Myers Squibb’s mavacamten (Camzyos) to ...
The 50-page document outlines what the FDA would like to see as vendors submit their technologies for regulatory review. It ...
The new device, designed to perform mitral valve repair in patients with functional MR, was co-invented by cardiologist Samir ...
According to new data from SullivanCotter, compensation in the United States is up more than 20% in the last five years for ...
Artificial intelligence (AI) is increasingly being incorporated into cardiovascular imaging, but at Mass General Brigham, some of the most practical applications are focused on st ...
FastWave Medical's laser intravascular lithotripsy system successfully fractured calcified coronary artery lesions in 30 ...
A new analysis found that one approach may outperform the other when it comes to minimizing the patient's risk of major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results